-The Hindu In a major boost to the country’s private vaccine manufacturing pharmaceutical companies, the World Health Organisation (WHO) has said that India’s national regulatory authority — Central Drugs Standard Control Organisation (CDSCO) — and its affiliated institutions meet the prescribed international standards. India is a major vaccine producer with 12 major vaccine manufacturing facilities. These vaccines are used for the national and international market, reaching nearly 150 countries. Every second child...

-Oxfam Blog As Oxfam’s two week online debate on the future of agriculture gets under way, John Ambler of Oxfam America imagines how it could all turn out right in the end. It is now 2050.  Globally, we are 9 billion strong.  Only 20% of us are directly involved in agriculture, and poor country economies have diversified.  Yet we all have enough food.  Technological innovation has played its part, but increased production...

-Outlook Its ploy of Aadhar-hinged cash transfer may have won the Congress political points, but will it really be a game-changer?   State-Wise     40% of the 22 crore Aadhar numbers are in Andhra Pradesh (4.7 crore) and Maharashtra (4 crore)     20% is what the two politically sensitive, Congress-ruled states account for of the 51 districts where DCT will be rolled out     55 lakh Aadhar numbers in TMC-run West Bengal. BJP-ruled Gujarat (57...

-The Business Standard Full country coverage, in stages, by April 2014 UIDAI, FinMin given prime responsibility to work with ministries, states for national coverage The government today made its intention clear of exploiting an Aadhaar-based direct cash transfer system as a political plank in the next Lok Sabha polls, due in 2014. Prime Minister Manmohan Singh today cleared the schedule for implementation from January 1 of government subsidies and entitlements to beneficiaries...

-Outlook The government today cleared the National Pharmaceutical Pricing Policy that will bring 348 essential drugs under price control, leading to reduction in prices. "The National Pharmaceutical Pricing policy has been approved by the Cabinet with an objective to put in place a regulatory framework for pricing of drugs to ensure their availability at reasonable prices," an official source said. At present, the government through the National Pharmaceutical Pricing Authority (NPPA) controls prices...